References
- Rybicki BA, Major M, Jr PJ, Maliank Mjlannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997;145(3):234–241. doi:10.1093/oxfordjournals.aje.a009096.
- Prasse A. The diagnosis, differential diagnosis, and treatment of sarcoidosis. Dtsch Arztebl Int. 2016;113:565–574.
- Venkatesh P, Gogia V, Shah B, et al. Patterns of uveitis at the Apex Institute for Eye Care in India: results from a prospectively enrolled patient data base. Int Ophthalmol. 2016;36:365–372. doi:10.1007/s10792-015-0128-9.
- Rothova A. Ocular involvement in sarcoidosis. Br J Ophthalmol. 2000;84(1):110–116. doi:10.1136/bjo.84.1.110.
- Atmaca LS, Atmaca-Sonmez P, Idil A, Kumbasar OO, Celik G. Ocular involvement in sarcoidosis. Ocul Immunol Inflamm. 2009;17(2):91–94. doi:10.1080/09273940802596526.
- Ohara K, Okubo A, Sasaki H, Kamata K. Intraocular manifestations of systemic sarcoidosis. Jpn J Ophthalmol. 1992;36:452–457.
- Heiligenhaus A, Wefelmeyer D, Wefelmeyer E, Rosel M, Schrenk M. The eye as a common site for the early clinical manifestation of sarcoidosis. Ophthalmic Res. 2011;46(1):9–12. doi:10.1159/000321947.
- Rothova A, Alberts C, Glasius E, Kijlstra A, Buitenhuis HJ, Breebaart AC. Risk factors for ocular sarcoidosis. Doc Ophthalmol. 1989;72(3–4):287–296. doi:10.1007/BF00153496.
- Dana MR, Merayo-Lloves J, Schaumberg DA, Foster CS. Prognosticators for visual outcome in sarcoid uveitis. Ophthalmology. 1996;103(11):1846–1853. doi:10.1016/S0161-6420(96)30417-X.
- Abad S, Meyssonier V, Allali J, et al. Association of peripheral multifocal choroiditis with sarcoidosis: a study of thirty-seven patients. Arthritis Rheum. 2004;51(6):974–982. doi:10.1002/art.20839.
- Ossewaarde-van Norel J, Ten Dam-van Loon N, De Boer JH, Rothova A. Long-term visual prognosis of peripheral multifocal chorioretinitis. Am J Ophthalmol. 2015;159(4):690–697. doi:10.1016/j.ajo.2015.01.005.
- Han YS, Rivera-Grana E, Salek S, et al. Distinguishing Uveitis secondary to sarcoidosis from idiopathic disease cardiac implications. JAMAOphthalmol. 2018;136(2):109–115.
- Herbort CP, Rao NA, Mochizuki M; Members of Scientific Committee of First International Workshop on Ocularsarcoidosis. International criteria for the diagnosis of ocular sarcoidosis: results of the first International workshop on ocular sarcoidosis (IWOS). Ocul Immunol Inflamm. 2009;17(3):160–169.
- Nishiyama Y, Yamamoto Y, Fukunaga K, et al. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis. J Nucl Med. 2006;47:1571–1576.
- Gilbert S, Steinbrech DS, Landas SK, Hunninghake GW. Amounts of angiotensin-converting enzyme mRNA reflect the burden of granulomas in granulomatous lung disease. Am Rev Respir Dis. 1993;148:483–486. doi:10.1164/ajrccm/148.2.483.
- Mostard RL, Vöö S, van Kroonenburgh MJ, et al. Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis. Respir Med. 2011;105:1917–1924. doi:10.1016/j.rmed.2011.08.012.